WBH Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.32M | Sell |
6,122
-132
| -2% | -$29.3K | 0.1% | 145 |
|
|
2025
Q4 | $1.43M | Buy |
6,254
+200
| +3% | +$45.6K | 0.11% | 132 |
|
|
2025
Q3 | $1.4M | Sell |
6,054
-375
| -6% | -$76.4K | 0.11% | 134 |
|
|
2025
Q2 | $1.19M | Sell |
6,429
-451
| -7% | -$83.8K | 0.1% | 142 |
|
|
2025
Q1 | $1.44M | Buy |
6,880
+283
| +4% | +$55K | 0.13% | 117 |
|
|
2024
Q4 | $1.17M | Sell |
6,597
-662
| -9% | -$122K | 0.11% | 136 |
|
|
2024
Q3 | $1.43M | Sell |
7,259
-50
| -0.7% | -$9.33K | 0.14% | 119 |
|
|
2024
Q2 | $1.25M | Sell |
7,309
-24
| -0.3% | -$3.98K | 0.13% | 126 |
|
|
2024
Q1 | $1.34M | Sell |
7,333
-26
| -0.4% | -$4.48K | 0.14% | 123 |
|
|
2023
Q4 | $1.14M | Sell |
7,359
-91
| -1% | -$13.3K | 0.13% | 140 |
|
|
2023
Q3 | $1.11M | Sell |
7,450
-44
| -0.6% | -$6.46K | 0.14% | 134 |
|
|
2023
Q2 | $1.01M | Sell |
7,494
-100
| -1% | -$14.7K | 0.12% | 144 |
|
|
2023
Q1 | $1.21M | Buy |
+7,594
| New | +$1.16M | 0.15% | 134 |
|
|
2022
Q3 | $1.36M | Sell |
10,120
-5
| -0% | -$717 | 0.2% | 113 |
|
|
2022
Q2 | $1.55M | Hold |
10,125
| – | – | 0.21% | 105 |
|
|
2022
Q1 | $1.58M | Sell |
10,125
-741
| -7% | -$108K | 0.19% | 107 |
|
|
2021
Q4 | $1.47M | Buy |
10,866
+368
| +4% | +$43.5K | 0.17% | 121 |
|
|
2021
Q3 | $1.13M | Hold |
10,498
| – | – | 0.15% | 124 |
|
|
2021
Q2 | $1.24M | Sell |
10,498
-251
| -2% | -$28.3K | 0.18% | 104 |
|
|
2021
Q1 | $1.16M | Sell |
10,749
-165
| -2% | -$17.6K | 0.19% | 107 |
|
|
2020
Q4 | $1.23M | Sell |
10,914
-50
| -0.5% | -$4.8K | 0.21% | 98 |
|
|
2020
Q3 | $960K | Sell |
10,964
-235
| -2% | -$22.1K | 0.19% | 104 |
|
|
2020
Q2 | $1.1M | Buy |
11,199
+201
| +2% | +$17.7K | 0.27% | 91 |
|
|
2020
Q1 | $837 | Sell |
10,998
-621
| -5% | -$52.9K | 0.2% | 98 |
|
|
2019
Q4 | $1.03M | Sell |
11,619
-89
| -0.8% | -$7.39K | 0.21% | 102 |
|
|
2019
Q3 | $886K | Sell |
11,708
-1,394
| -11% | -$95.6K | 0.2% | 114 |
|
|
2019
Q2 | $952K | Buy |
13,102
+60
| +0.5% | +$4.72K | 0.22% | 98 |
|
|
2019
Q1 | $1.05M | Buy |
13,042
+7
| +0.1% | +$573 | 0.25% | 95 |
|
|
2018
Q4 | $1.2K | Sell |
13,035
-46
| -0.4% | -$4.04K | 0.29% | 79 |
|
|
2018
Q3 | $1.24M | Sell |
13,081
-1,794
| -12% | -$170K | 0.3% | 83 |
|
|
2018
Q2 | $1.38M | Sell |
14,875
-430
| -3% | -$42K | 0.36% | 65 |
|
|
2018
Q1 | $1.45M | Sell |
15,305
-121
| -0.8% | -$13.3K | 0.39% | 60 |
|
|
2017
Q4 | $1.49M | Buy |
15,426
+204
| +1% | +$19.2K | 0.4% | 62 |
|
|
2017
Q3 | $1.35M | Sell |
15,222
-1,074
| -7% | -$81.8K | 0.38% | 66 |
|
|
2017
Q2 | $1.18M | Sell |
16,296
-45
| -0.3% | -$3.02K | 0.33% | 69 |
|
|
2017
Q1 | $1.06M | Buy |
16,341
+55
| +0.3% | +$3.46K | 0.32% | 75 |
|
|
2016
Q4 | $1.02M | Sell |
16,286
-577
| -3% | -$35.2K | 0.34% | 67 |
|
|
2016
Q3 | $1.06M | Buy |
16,863
+461
| +3% | +$29.8K | 0.36% | 64 |
|
|
2016
Q2 | $1.01M | Sell |
16,402
-141
| -0.9% | -$8.59K | 0.4% | 57 |
|
|
2016
Q1 | $944K | Buy |
16,543
+5
| +0% | +$279 | 0.32% | 64 |
|
|
2015
Q4 | $979 | Sell |
16,538
-72
| -0.4% | -$4.15K | 0.34% | 60 |
|
|
2015
Q3 | $903K | Sell |
16,610
-1,454
| -8% | -$94.6K | 0.38% | 65 |
|
|
2015
Q2 | $1.21M | Sell |
18,064
-1,497
| -8% | -$97.7K | 0.48% | 56 |
|
|
2015
Q1 | $1.15K | Buy |
19,561
+81
| +0.4% | +$4.89K | 0.32% | 59 |
|
|
2014
Q4 | $1.27M | Buy |
19,480
+316
| +2% | +$19.9K | 0.48% | 50 |
|
|
2014
Q3 | $1.11M | Sell |
19,164
-393
| -2% | -$21.8K | 0.39% | 58 |
|
|
2014
Q2 | $1.1M | Sell |
19,557
-743
| -4% | -$39K | 0.42% | 60 |
|
|
2014
Q1 | $1.04M | Sell |
20,300
-298
| -1% | -$15.1K | 0.41% | 62 |
|
|
2013
Q4 | $1.09M | Buy |
20,598
+282
| +1% | +$13.9K | 0.44% | 59 |
|
|
2013
Q3 | $909K | Sell |
20,316
-928
| -4% | -$41.1K | 0.41% | 64 |
|
|
2013
Q2 | $878K | Buy |
+21,244
| New | +$929K | 0.41% | 63 |
|
Other funds holding ABBV
VCM
VPM
WBH Advisory's ABBV Position: Q1 2026 in Review
WBH Advisory reduced its AbbVie (ABBV) stake by 2.1% in Q1 2026, selling an estimated $29.3K and leaving 6,122 shares worth $1.32M. The position accounts for 0.1% of the portfolio, ranked #145.
WBH Advisory first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.58M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- WBH Advisory held 6,122 shares of AbbVie worth $1.32M as of Q1 2026.
- WBH Advisory sold 132 AbbVie shares in Q1 2026, an estimated $29.3K.
- AbbVie made up 0.1% of WBH Advisory's portfolio in Q1 2026, its #145 holding.
- WBH Advisory first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- WBH Advisory's AbbVie position peaked at $1.58M in Q1 2022.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on WBH Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.